March 14th 2025
Data show people with pulmonary arterial hypertension tend to stay in the hospital longer and have higher medical bills.
March 7th 2025
The drug’s developer, Cereno Scientific, believes its oral therapy could have a major impact on the pulmonary arterial hypertension market.
March 5th 2025
New research could pave the way toward a new method of pulmonary arterial hypertension diagnosis and monitoring.
February 7th 2025
Women are more likely to have pulmonary arterial hypertension, but men tend to have worse outcomes and worse treatment responses.
February 5th 2025
Gossamer also reported encouraging preclinical data related to the combination of seralutinib and Winrevair.
Fighting Disparities and Saving Lives: An Exploration of Challenges and Solutions in Cancer Care
View More